Meeting of the National Vaccine Advisory Committee, 55467-55468 [2016-19847]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 161 / Friday, August 19, 2016 / Notices
Services Administration, 5600 Fishers
Lane, Room 15N39, Rockville, Maryland
20857; (2) call (301) 443–0430; or (3)
send an email to jweiss@hrsa.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Service
Administration
mstockstill on DSK3G9T082PROD with NOTICES
Advisory Committee on Training in
Primary Care Medicine and Dentistry;
Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Committee on
Training in Primary Care Medicine and
Dentistry (ACTPCMD).
Dates and Times: September 9, 2016.
Place: Webinar/Conference Call
Component.
Status: The meeting will be open to
the public.
Purpose: The ACTPCMD provides
advice and recommendations on a broad
range of issues relating to grant
programs authorized by Title VII, Part C,
sections 747 and 748 of the Public
Health Service Act (PHSA). During the
September 9, 2016 meeting, the
Committee will continue work on the
ACTPCMD 14th report integrating
behavioral health content into primary
care medicine and oral health training
program.
Agenda: The ACTPCMD agenda will
be available 2 days prior to the meeting
on the HRSA Web site at https://
www.hrsa.gov/advisorycommittees/
bhpradvisory/actpcmd/.
SUPPLEMENTARY INFORMATION: Requests
by members of the public to make oral
comments or provide written comments
to the ACTPCMD should be sent to Dr.
Joan Weiss, Designated Federal Official,
using the address and phone number
below. Individuals who plan to
participate on the conference call and
webinar should notify Dr. Weiss at least
3 days prior to the meeting, using the
address and phone number below.
Interested parties should refer to the
meeting subject as the HRSA Advisory
Committee on Training in Primary Care
Medicine and Dentistry or ACTPCMD.
• The conference call-in number is 1–
800–619–2521. The passcode is
9271697.
• The webinar link is https://
hrsa.connectsolutions.com/actpcmd.
Contact: Anyone requesting
information regarding the ACTPCMD
should contact Dr. Joan Weiss,
Designated Federal Official within the
Bureau of Health Workforce, Health
Resources and Services Administration,
in one of three ways: (1) Send a request
to the following address: Dr. Joan Weiss,
Designated Federal Official, Bureau of
Health Workforce, Health Resources and
VerDate Sep<11>2014
18:08 Aug 18, 2016
Jkt 238001
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–19815 Filed 8–18–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services is hereby giving notice that the
National Vaccine Advisory Committee
(NVAC) will hold a meeting September
20, 2016. The meeting is open to the
public. However, pre-registration is
required for both public attendance and
public comment. Individuals who wish
to attend the meeting and/or participate
in the public comment session should
register at https://www.hhs.gov/nvpo/
nvac/meetings/upcomingmeetings.
Participants may also register by
emailing nvpo@hhs.gov or by calling
(202) 690–5566 and providing their
name, organization, and email address.
DATES: The meeting will be held on
September 20, 2016. The meeting times
and agenda will be posted on the NVAC
Web site at https://www.hhs.gov/nvpo/
nvac/meetings/upcomingmeetings as
soon as they become available.
ADDRESSES: U.S. Department of Health
and Human Services, Hubert H.
Humphrey Building, the Great Hall, 200
Independence Avenue SW.,
Washington, DC 20201.
The meeting can also be accessed
through a live webcast the day of the
meeting. For more information, visit
https://www.hhs.gov/nvpo/nvac/
meetings/upcomingmeetings.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; email:
nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
55467
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The NVAC was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
The September 2016 NVAC meeting
will include a discussion of the 2010
National Vaccine Plan Mid-course
Review. The NVAC’s Mid-course
Review Working Group and the
Maternal Immunization Working Group
will also present their findings and
recommendations for deliberation and
vote by the Committee. Members will
also receive an update on the recently
released CDC Strategic Framework for
Global Immunizations. Please note that
agenda items are subject to change as
priorities dictate. Information on the
final meeting agenda will be posted
prior to the meeting on the NVAC Web
site: https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is
limited to the available space.
Individuals who plan to attend in
person and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the National Vaccine
Program Office at the address/phone
listed above at least one week prior to
the meeting. For those unable to attend
in person, a live webcast will be
available. More information on
registration and accessing the webcast
can be found at https://www.hhs.gov/
nvpo/nvac/meetings/
upcomingmeetings.
Members of the public will have the
opportunity to provide comments at the
NVAC meeting during the public
comment periods designated on the
agenda. Public comments made during
the meeting will be limited to three
minutes per person to ensure time is
allotted for all those wishing to speak.
Individuals are also welcome to submit
their written comments. Written
comments should not exceed three
pages in length. Individuals submitting
written comments should email their
comments to the National Vaccine
Program Office (nvpo@hhs.gov) at least
five business days prior to the meeting.
E:\FR\FM\19AUN1.SGM
19AUN1
55468
Federal Register / Vol. 81, No. 161 / Friday, August 19, 2016 / Notices
Dated: August 4, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine
Advisory Committee, Deputy Assistant
Secretary for Health, Director, National
Vaccine Program Office.
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
[FR Doc. 2016–19847 Filed 8–18–16; 8:45 am]
Dated: August 15, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–19771 Filed 8–18–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Human Genome Research Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Human Genome Research Institute,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK3G9T082PROD with NOTICES
National Human Genome Research
Institute Notice of Closed Meeting
National Institutes of Health
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: September 7–8, 2016.
Time: September 07, 2016, 2:00 p.m. to
9:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Regency Annex
Room (Ballroom Level), 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: September 08, 2016, 8:00 a.m. to
6:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, Room B1C211 (FAES Room 1),
10 Center Drive, Bethesda, MD 20892.
Contact Person: Monica Berger, Executive
Secretary, Office of the Scientific Director,
National Human Genome Research Institute,
50 South Drive, Bldg. 50, Rm. 5222,
Bethesda, MD 20892, 301–294–6873,
bergerm@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
VerDate Sep<11>2014
18:08 Aug 18, 2016
Jkt 238001
Scientific Advisory Committee on
Alternative Toxicological Methods;
Announcement of Meeting; Request
for Comments
This notice announces a
meeting of the Scientific Advisory
Committee on Alternative Toxicological
Methods (SACATM). SACATM advises
the Interagency Coordinating Committee
on the Validation of Alternative
Methods (ICCVAM), the National
Toxicology Program (NTP) Interagency
Center for the Evaluation of Alternative
Toxicological Methods (NICEATM), and
the Director of the National Institute of
Environmental Health Sciences (NIEHS)
and NTP regarding statutorily mandated
duties of ICCVAM and activities of
NICEATM. The meeting is open to the
public, and registration is requested for
both public attendance and oral
comment and required to access the
webcast. Information about the meeting
and registration is available at https://
ntp.niehs.nih.gov/go/32822.
DATES:
Meeting: September 27, 2016; it
begins 8:30 a.m. Eastern Daylight Time
(EDT) and continues until adjournment.
Written Public Comment
Submissions: Deadline is September 13,
2016. Registration for Meeting and/or
Oral Comments: Deadline is September
20, 2016.
Registration to View Webcast:
Deadline is September 27, 2016.
Registration to view the meeting via the
webcast is required.
ADDRESSES:
Meeting Location: Rodbell
Auditorium, Rall Building, NIEHS, 111
T.W. Alexander Drive, Research
Triangle Park, NC 27709.
Meeting Web page: The preliminary
agenda, registration information, and
background materials should be posted
at https://ntp.niehs.nih.gov/go/32822 by
August 16, 2016.
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Webcast: The meeting will be
webcast; the URL will be provided to
those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr.
Lori White, Designated Federal Officer
for SACATM, Office of Liaison, Policy,
and Review, Division of NTP, NIEHS,
P.O. Box 12233, K2–03, Research
Triangle Park, NC 27709. Phone: 919–
541–9834, fax: 301–480–3272, email:
whiteld@niehs.nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2124, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Preliminary Agenda and Other
Meeting Information: A preliminary
agenda, roster of SACATM members,
and background materials should be
available by August 16, 2016, on the
SACATM meeting Web site (https://
ntp.niehs.nih.gov/go/32822) and
available upon request from the
Designated Federal Officer. Public
comments and any additional
information will be posted when
available. Following the meeting,
summary minutes will be prepared and
available on the SACATM Web site or
upon request from the Designated
Federal Officer.
Meeting and Registration: This
meeting is open to the public with time
scheduled for oral public comments.
The public may attend the meeting at
NIEHS, where attendance is limited
only by the space available, or view the
webcast. Registration is required to view
the webcast; the URL for the webcast
will be provided in the email
confirming registration. Individuals who
plan to attend and/or provide oral
comments are encouraged to register at
https://ntp.niehs.nih.gov/go/32822 by
September 20, 2016, to facilitate
planning for the meeting. Individuals
are encouraged to access the Web site to
stay abreast of the most current
information regarding the meeting.
Visitor and security information for
those attending in person is available at
niehs.nih.gov/about/visiting/index.cfm.
Individuals with disabilities who need
accommodation to participate in this
event should contact Ms. Robbin Guy at
phone: 919–541–4363 or email: guyr2@
niehs.nih.gov. TTY users should contact
the Federal TTY Relay Service at 800–
877–8339. Requests should be made at
least five business days in advance of
the event.
Request for Comments: Both written
and oral public input on the agenda
topics is invited. Written comments
submitted in response to this notice
should be received by September 13,
2016. Comments will be posted on the
SACATM meeting Web site and persons
submitting them will be identified by
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 81, Number 161 (Friday, August 19, 2016)]
[Notices]
[Pages 55467-55468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19847]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services is hereby giving notice that
the National Vaccine Advisory Committee (NVAC) will hold a meeting
September 20, 2016. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment.
Individuals who wish to attend the meeting and/or participate in the
public comment session should register at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings. Participants may also register by emailing
nvpo@hhs.gov or by calling (202) 690-5566 and providing their name,
organization, and email address.
DATES: The meeting will be held on September 20, 2016. The meeting
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings as soon as they become
available.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, the Great Hall, 200 Independence Avenue SW.,
Washington, DC 20201.
The meeting can also be accessed through a live webcast the day of
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.
FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S.
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone:
(202) 690-5566; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The NVAC was established to provide advice and
make recommendations to the Director of the National Vaccine Program on
matters related to the Program's responsibilities. The Assistant
Secretary for Health serves as Director of the National Vaccine
Program.
The September 2016 NVAC meeting will include a discussion of the
2010 National Vaccine Plan Mid-course Review. The NVAC's Mid-course
Review Working Group and the Maternal Immunization Working Group will
also present their findings and recommendations for deliberation and
vote by the Committee. Members will also receive an update on the
recently released CDC Strategic Framework for Global Immunizations.
Please note that agenda items are subject to change as priorities
dictate. Information on the final meeting agenda will be posted prior
to the meeting on the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend in person and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the National Vaccine Program Office at
the address/phone listed above at least one week prior to the meeting.
For those unable to attend in person, a live webcast will be available.
More information on registration and accessing the webcast can be found
at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.
Members of the public will have the opportunity to provide comments
at the NVAC meeting during the public comment periods designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit their written
comments. Written comments should not exceed three pages in length.
Individuals submitting written comments should email their comments to
the National Vaccine Program Office (nvpo@hhs.gov) at least five
business days prior to the meeting.
[[Page 55468]]
Dated: August 4, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy
Assistant Secretary for Health, Director, National Vaccine Program
Office.
[FR Doc. 2016-19847 Filed 8-18-16; 8:45 am]
BILLING CODE 4150-44-P
